Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
Abstract Background Increasing evidence suggests that immunotherapy, especially immune checkpoint inhibitors (ICIs), has the potential to facilitate long-term survival in various cancer besides prostate cancer. Emerging evidence indicated that pyroptosis, an immunogenic form of cell death, could tri...
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
BMC
2023-08-01
|
| Серии: | Experimental Hematology & Oncology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40164-023-00428-9 |